Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shusuke Akamatsu

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2023
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC studyLeandro Blas, Masaki Shiota, Hideaki Miyake, et al.
JCO Clinical Cancer Informatics|April 25, 2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC StudyMasaki Shiota, Shota Nemoto, Ryo Ikegami, et al.
Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
BMC Cancer|February 17, 2019
The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patientsNaoki Terada, Toshiyuki Kamoto, Hiromasa Tsukino, et al.
JNCI Cancer Spectrum|February 4, 2022
Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate BiopsyShusuke Akamatsu, Naoki Terada, Ryo Takata, et al.
Clinical Genitourinary Cancer|July 31, 2025
Risk Stratification for the Prognosis of Patients With pT3aN0M0 Clear Cell Renal Cell CarcinomaShigeki Koterazawa, Takayuki Sumiyoshi, Katsuhiro Ito, et al.
Iscience|June 24, 2026
IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft modelRyuta Sobu, Yuka Kobayashi, Soki Kashima, et al.
Nature Communications|December 13, 2023
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinomaMiyuki Nomura, Mai Ohuchi, Yoshimi Sakamoto, et al.
Cell Reports|August 4, 2015
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2024
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC StudyTokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2023
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC studyLeandro Blas, Masaki Shiota, Hideaki Miyake, et al.
JCO Clinical Cancer Informatics|April 25, 2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC StudyMasaki Shiota, Shota Nemoto, Ryo Ikegami, et al.
Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
BMC Cancer|February 17, 2019
The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patientsNaoki Terada, Toshiyuki Kamoto, Hiromasa Tsukino, et al.
JNCI Cancer Spectrum|February 4, 2022
Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate BiopsyShusuke Akamatsu, Naoki Terada, Ryo Takata, et al.
Clinical Genitourinary Cancer|July 31, 2025
Risk Stratification for the Prognosis of Patients With pT3aN0M0 Clear Cell Renal Cell CarcinomaShigeki Koterazawa, Takayuki Sumiyoshi, Katsuhiro Ito, et al.
Iscience|June 24, 2026
IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft modelRyuta Sobu, Yuka Kobayashi, Soki Kashima, et al.
Nature Communications|December 13, 2023
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinomaMiyuki Nomura, Mai Ohuchi, Yoshimi Sakamoto, et al.
Cell Reports|August 4, 2015
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2024
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC StudyTokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, et al.
Pageof 21